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DEDD spells death to caspase substrates
 
he major apoptotic effector protein caspase-3 holds the 
power to destroy a huge number of proteins in a cell—over 34 
thousand human proteins with a caspase-3 cleavage motif have  T
 
been sequenced. Nevertheless, apoptosis 
proceeds in an ordered fashion; only 
specific substrates are cleaved at the 
proper time. On page 1051, Lee et al.
describe a new function of the apoptosis 
regulator DEDD as a scaffolding protein 
that directs this orderly destruction.
DEDD works by bringing together 
the important participants, much like 
scaffolding proteins that control signaling 
cascades. DEDD resides mainly in the 
cytosol, despite its previous identification 
based on its DNA-binding death effector 
domain (DED). Localization studies 
by Lee et al. revealed that, even in 
nonapoptotic epithelial cells, DEDD 
associated with the keratin intermediate 
DEDD (red) brings active caspase-3 (green) 
to its substrates.
 
filament network. Once apoptosis was induced, an apoptosis-
related epitope within the DED of DEDD was exposed in 
a caspase-3–dependent manner.
 
Gnawing at the bone
 
he destructive ability of osteo-
clasts (OCs) to weaken bones is 
reduced by the interaction between 
an extracellular matrix (ECM) ligand 
and an adhesion receptor, according 
to results from Spessotto et al. on 
page 1133.
The correct balance between 
bone-destroying OCs and bone-
generating osteoblasts maintains 
bone mass in adults. However, too 
much OC activity can cause diseases 
like osteoporosis and rheumatoid 
arthritis. OCs are derived from 
hematopoietic precursors that leave 
the bloodstream and migrate toward 
the bone surface. Once they reach 
their destination, the precursors stop 
migrating and differentiate into OCs, 
which secrete cysteine proteases that 
chew up the bone.
Other proteases, namely matrix 
metalloproteases (MMPs), are thought 
T
 
to help mobilize OCs by degrading 
small pieces of the ECM. As such, 
Spessotto et al. were not surprised to 
find that reducing MMP-9 expression 
OCs adhere when HA/CD44 
binding inhibits MMP-9 expression.
 
in OCs led to a shift from OC migration 
to adherence.
What they did not anticipate was 
what causes MMP-9 inhibition in 
vivo. MMP-9 expression was reduced 
and migration ceased when cells 
encountered hyaluronic acid (HA), 
an ECM component. The cells bind 
HA via CD44, and this engagement 
normally promotes cell motility, as 
seen in melanoma cells. But OCs 
migrating in vitro on various other 
ECM components, including laminin 
and fibronectin, stopped when they 
encountered HA. They also stopped 
when MMP-9 activity was inhibited, 
either chemically or using antisense 
techniques. The group does not 
yet know how HA binding elicits 
MMP-9 down-regulation, but they 
have initial evidence that HA also 
inhibits motility in certain tumor 
cells. 
 
 
 
Activated DEDD returns the favor by bringing caspase-3 
to its keratin substrate. Active caspase-3 localized almost entirely 
to keratin filaments, suggesting that keratin is its main substrate 
in epithelial cells. Later in apoptosis, 
DEDD, caspase-3, and fragments of 
keratin filaments formed inclusion 
bodies that eventually moved into 
apoptotic blebs.
Ubiquitination of DEDD at apoptosis 
may regulate its scaffolding activity, 
as keratin and caspase-3 only associated 
with diubiquitinated DEDD. When 
DEDD could not be ubiquitinated, 
keratin filaments remained intact. 
Caspase-3 also remained largely inactive, 
indicating that DEDD further activates 
the protease and thereby regulates the 
destruction of substrates beyond keratin. 
The lag between the initial activation 
of caspase-3 by cytochrome 
 
c
 
 and later 
caspase-3 activation by DEDD may ensure that only small 
amounts of the protease are active until it reaches its main 
cytoskeletal target.
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